Denali Advisors »

Eagle Pharmaceuticals shares owned by Denali Advisors

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Denali Advisors from 13F filings

Historical chart of Denali Advisors investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Denali Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Denali Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $139k 27k 5.24
2023-12-31 $139k 27k 5.23
2023-09-30 $509k 32k 15.77
2023-06-30 $412k 21k 19.44
2023-03-31 $57k 2.0k 28.37
2022-12-31 $59k 2.0k 29.23